Efficacy of naftidrofuryl in patients with vascular or mixed dementia: Results of a multicenter, double-blind trial

Clinical Therapeutics

Volumn 22, Issue 7, 2000, Pages 834-844

  Emeriau, Jean Paul ^a   Lehert, Philippe ^b   Mosnier, Michel ^c  

^a Ctr Geriatrie Ctr Hosp Univ B   (France)

^b UNIVERSITY OF MONS   (Belgium)

^c Cardiovascular Unit   (France)

Author keywords

ADAS cog; MMSE; Naftidrofuryl; Vascular and mixed dementia

Indexed keywords

NAFTIDROFURYL;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MENTAL HEALTH; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 0033895841     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)80056-9     Document Type: Article

References (61)

1. Epidemiologie et panorama etiologique des demences
2. Demences: Problemes diagnostiques
3. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop
4. Dementia with Lewy bodies: Review and pharmacotherapeutic implications
5. Personnes agees: Demographie, aides economiques et sociales, institutions sanitaires et sociales
6. Perte d'autonomie du sujet age: Etiologie, moyens d'evaluation, consequences sur la prise en charge medico-sociale
7. Demences vasculaires: Definition, epidemiologie et diagnostic
8. Epidemiology of vascular dementia
9. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DMS IV, ICD 10, NINDS-AIREN)
10. Neuropsychological, psychiatric and cerebral blood flow findings in vascular dementia and Alzheimer's disease
11. Cerebral blood flow in dementia
12. Single photon emission computerized tomography in elderly patients with Alzheimer's disease and multi-infarct dementia
13. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
14. Biochemical and physiological evidences for antiserotonergic properties of naftidrofuryl
15. 2 antagonist, naftidrofuryl, exhibited a protective effect on ischaemic neuronal damage in the gerbil
16. Naftidrofuryl inhibits contractions to serotonin in intact and de-endothelialized cerebral arteries in vitro
17. Involvement of serotonergic neuronal systems in the anti-amnesic action of naftidrofuryl oxalate
18. 2 receptors in mouse brain: Evaluation based on quantitative autoradiography and head-twitch response
19. In vivo effect of naftidrofuryl on 5-hydroxy-tryptamine-mediated constriction in rat peripheral microcirculation
20. Influence of naftidrofuryl, a serotonergic antagonist, on erythrocyte aggregation
21. Platelet aggregation after naftidrofuryl application in vitro and ex vivo
22. Effect of naftidrofuryl and aspirin on platelet aggregation in peripheral vascular disease
23. Naftidrofuryl inhibits the release of 5-hydroxytryptamine and platelet-derived growth factor from human platelets
24. The effect of naftidrofuryl on the metabolic response to exercise in man
25. Un nouveau promoteur de croissance nerveuse: Le naftidrofuryl
26. Naftidrofuryl, a putative activator of neuron survival, stimulates the expression of neurofilament heavy subunit in cultivated spinal cord neurons from chicken
27. Prevention par le naftidrofuryl de la neuropathie peridipherique induite par la vincristine - Une etude controlee versus placebo d'une serie de 29 cas
28. Effect of naftidrofuryl on metabolism and survival of cultured neurons
29. Effects of naftidrofuryl on the time course of the regional cerebral blood flow in acute ishemic stroke
30. Naftidrofuryl protects neurons against ischemic damage
31. Effet du naftidrofuryl sur la repousse axonale
32. Experimental and clinical study of the effect of naftidrofuryl on the recovery from peripheral nerve lesions
33. Effets du naftidrofuryl sur le metabolisme energetique cerebral chez la souris - Deuxieme partie
34. Electro-physiological evaluation of the effects of naftidrofuryl on skeletal muscle reinnervation in the rat
35. Postischaemic breakdown in hippocampal protein synthesis and amnesic deficits in rats: Pharmacological improvement by curative naftidrofuryl treatment
36. Etude double-aveugle de l'efficacite du naftidrofuryl dans les troubles cognitifs lies a la senescence
37. The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia
38. A double-blind trial of naftidrofuryl in treating confused elderly patients in general practice
39. Controlled trial of naftidrofuryl in dementia in old age
40. Preliminary report of a long-term double-blind study on naftidrofuryl and placebo in mild demented elderly patients Alzheimer's type (SDAT)
41. Naftidrofuryl in the treatment of mild senile dementia. A double-blind study
42. Action combinee de Praxilene et d'exercices d'entrainement mental sur les troubles de la memoire de sujets ages
43. The effect of naftidrofuryl oxalate (LS 121) on learning and memory
44. Study of naftidrofuryl versus placebo in age associated cognitive impairment on an outpatient basis
45. Studio clinical a lungo termine sui naftidrofurile nei trattamento dell'insufficienza cerebrale senile
46. Efficacy of naftidrofuryl in patients with moderate senile dementia
47. Wirksamkeit und Vertraglichkeit von Naftidrofuryl bei Multi-Infarkt-Demenz: Eine placebo-kontrollierte Doppelblind-Studie
48. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease
49. Le 'Mini Mental State' (MMS) - Un outil pratique pour l'evaluation de l'etat cognitif des patients par le clinicien
50. Mini-Mental State, a practical method for grading the cognitive state of patients for the clinician
51. Le test elementaire de concentration, orientation et memoire-application au depistage d'un etat dementiel en pratique quotidienne
52. Utilisation du Mini Mental State (MMS)
53. MADRS (Montgomery and Asberg Depression Rating Scale) - A new depression scale designed to be sensitive to change
54. A new rating scale for Alzheimer's disease
55. Alzheimer Disease Assessment Scale: Useful for both early detection and staging of dementia of the Alzheimer type
56. Alzheimer Disease Assessment Scale: A subtest analysis
57. Presentation de l'adaptation en langue francaise par le groupe GRECO d'une echelle d'evaluation cognitive utilisee dans les demences de type Alzheimer